Skip Navigation
Print This Page
Share this page: More

Why is DVT/VTE important?

  • VTE is preventable. Effective prophylaxis reduces VTE incidence by 60 percent.
  • VTE is common, with at least 900,000 cases annually in the U.S. during or post-hospitalization. An additional 1 million estimated VTEs are not related to hospitalization.
  • VTE is deadly. At least one-third of patients with VTE die as a result of it.
  • VTE causes long-term morbidity.
  • VTE is recurrent in 40 percent of patients.
  • Each VTE incidence costs between $10,000 and $20,000, according to the Agency for Health care Research and Quality.
Quick Links
  • Register for a Course
  • Request a Speaker
  • Consult an Expert
  • Become a Sponsor
  • Contact Us

We've Changed Our Name

The Center for Innovation is now part of the new Armstrong Institute for Patient Safety and Quality. Learn more about the institute.


Please review training opportunities at the Armstrong Institute for a listing of upcoming workshops and online programs.

About Johns Hopkins - Find Out More


© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.